VNS for TBI group
DeviceGroup will be implanted with VNS device for chronic TBI
NCT Number: NCT07719829
This study is evaluating whether pairing vagus nerve stimulation (VNS) with structured upper limb rehabilitation therapy can improve arm and hand function in individuals with moderate to severe traumatic brain injury (TBI).
Many people who survive a TBI experience long-term weakness, poor coordination, and difficulty using one arm or hand. These motor impairments can significantly affect independence and quality of life. Traditional rehabilitation can help, but recovery is often incomplete.
Vagus nerve stimulation (VNS) is an FDA-approved therapy for certain neurological conditions and involves a small device implanted under the skin in the chest with a lead connected to the vagus nerve in the neck. The device delivers mild electrical pulses to the nerve. In this study, VNS will be paired with goal-directed upper limb rehabilitation exercises. The stimulation is delivered during specific movements in therapy sessions. This "paired stimulation" approach is designed to enhance neuroplasticity - the brain's ability to reorganize and form new connections - which may improve motor recovery.
The VNS device used in this study is FDA-approved for other conditions. However, its use paired with rehabilitation for upper limb recovery after traumatic brain injury is investigational.
Participants in this study will:
Undergo surgical implantation of the VNS device.
Participate in structured upper limb rehabilitation therapy sessions where stimulation is paired with specific movements.
Complete follow-up visits and assessments to measure changes in arm and hand function, strength, dexterity, and overall recovery.
The main goal of the study is to determine whether paired VNS and rehabilitation improves upper limb motor function compared to rehabilitation alone. Safety will also be closely monitored, including surgical outcomes and any device-related effects.
This study may help determine whether VNS paired with rehabilitation is a safe and effective way to enhance motor recovery after traumatic brain injury. Findings from this research could contribute to improved treatment strategies for individuals living with long-term motor impairments following TBI.
Participation is voluntary. All participants will be carefully evaluated to determine eligibility, and informed consent will be obtained before enrollment.
Trial opening soon.
Get Notified22 year–80 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group will be implanted with VNS device for chronic TBI
Time frame: 6 Weeks
Adverse events related to VNS device implantation or stimulation will be recorded and graded using CTCAE v5.0.
Time frame: 6 Weeks
Video-based kinematic analysis of upper limb range of motion, comparing baseline (pre-surgery) to post-training (6 weeks after VNS-paired rehabilitation).
Time frame: 1 Year
RS score (range 0 [no disability] to 29 [extreme vegetative state]; lower scores indicate better outcome). Magnitude of change will be used to estimate effect size for power calculation in a future multicenter randomized trial.
Time frame: 6 Weeks
CRS-R total score (range 0-23; higher scores indicate better neurobehavioral function), comparing baseline to post-training.
Time frame: 6 Weeks
Time (seconds) to complete standardized WMFT tasks; lower time indicates better function. Comparing baseline to post-training.
Time frame: 6 Weeks
FMA-UE score (range 0-66; higher scores indicate better motor function), comparing baseline to post-training.
Time frame: 1 Year
MAL Amount of Use and Quality of Movement subscales (range 0-5 each; higher scores indicate better real-world arm use).
Time frame: 1 Year
EQ-5D-5L index score (range 0 [death] to 1 [full health]; higher scores indicate better quality of life).
Contact information is provided by the study sponsor or research team.
Stony Brook University
Other
Acronym: VNS for TBI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07702513
Brain Diseases, Brain Injuries
Englewood, Colorado, United States
View Trial DetailsNCT02425527
Brain Diseases, Brain Injuries
Turku, Finland
View Trial DetailsNCT07613918
Brain Diseases, Brain Injuries
Madison, Wisconsin, United States
View Trial DetailsNCT07722702
Brain Diseases, Brain Edema
Banhā, Qalyobia, Egypt
View Trial Details